Immune Modulators Flashcards

1
Q

Action time of prednisone

A

Intermediate acting
12-36 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Action time of prednisolone and what makes it different from prednisone?

A

12-36 hours
This one also has parenteral administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dexamethasone acting time

A

Long acting
36 - 72 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Differences between prednisone and dexamethasone

A

Dexamethasone
- Long acting >36 hrs
- Can be given in oral, parenteral, and topical forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mechanism of action glucocorticoids + 7 things they decrease

A

Decrease NF-kB activation
= suppress T cell proliferation and IL-1, IL-6, TNF, IFN

Inhibit macrophage antigen processing

Decrease: PG, leukotrienes, histamine, PAF, bradykinin, NO, IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Glucocorticoid uses (4)

A
  • Transplant
  • GvHD
  • Autoimmune diseases: SLE, RA, SD, psoriasis, asthma
  • IBD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Glucocorticoids main side effect

A

Growth retardation (adeno atrophy) or Cushing’s

Others:
- Avascular bone necrosis
- Osteopenia, osteoporosis
- Cataracts
- Hypertension
- Hyperglycemia
- Hypercholesterolemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cyclosporine mechanism of action

A
  1. Forms a complex with cyclophilin
  2. Binds to serine/threonine phosphatase calcineurin and blocks Ca2+ action of activating calcineurin
  3. Disrupt NF-aT phosphorylation
  4. NF-aTs don’t translocate to nucleus

= no IL-2 transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Immunosuppresor uses (3)

A
  • Transplant
  • Autoimmune: RA, Crohn, psoriasis, nephrotic sx, asthma, DM type I, etc.
  • GvHD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cyclosporine ADME

A

A: 50% available oral or IM
D: 50-60% in RBC or lymphocytes. Highly lipophilic.
M: CYP3A4
E: bile/feces, breast milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cyclosporine side effects NHLTG

A

Nephrotoxicity
Hirsutism
LDL increase
Tremor
Gum hyperplasia

Others: hypertension, hyperK, hyper uric acid, viral infections, hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Meds that decrease cyclosporine concentration (3)

A
  • Phenobarbital
  • Phenytoin
  • Rifampin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Meds that decrease cyclosporine clearance (3)

A
  • Erythromycin
  • Ketoconazole
  • Grapefruit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Can cyclosporine and sirolimus be given together?

A

Yes but with time between.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Between cyclosporine, tacrolimus, and sirolimus, which is more potent?

A

Tacrolimus

*more toxic also

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tacrolimus mechanism of action

A

Also known as FK506, it’s an immunophilin that:
1. Binds to FKBP
2. Inhibit calcineurin phosphatase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tacrolimus ADME

A

A: food decreases absorption. Oral or IM
D: 75-99% protein bound
M: CYP3A
E: fecal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Tacrolimus side effects

A

Nephro and neurotoxicity
Hyper K
Hypertension
Hyperglycemia and DIABETES when combined with glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What medication type is rapamycin?

A

Sirolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Sirolimus mechanism of action

A
  1. Binds to FKBP12
  2. Binds to mTOR complex 1 and inhibits pathway
  3. Stops cell cycle phase between G1 and S
  4. Inhibit IL-2 RESPONSE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Sirolimus ADME

A

A: 15% availability oral
D: bound to albumin 40%
M: CYP3A4
E: feces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which has less renal toxicity: calcineurin inhibitors or proliferation inhibitors (sirolimus)?

A

Sirolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Sirolimus toxicity

A

Tolerizing effects
- Nephrotox
- HYPERLIPIDEMIA
- Hypertension
- Worsen proteinuria
- Lymphocele
- PANCYTOPENIA
- Mouth ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Methotrexate mechanism of action

A

FOLATE ANTAGONIM
- Inhibits dihydrofolate reductase
- No folic acid activation
= prevent purine and pyrimidine synthesis
= less cell proliferation

Other: inhibit spermine, cause transmethylation, inhibit release of adenosine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Methotrexate ADME
A: IV, IM, oral D: bound 50%, distributed to third-space fluids M: aldehyde oxidase in liver, intestinal flora E: urine
26
Methotrexate side effects NABPRT
- Nausea, vomit, diarrhea + ULCERS - Alopecia - Bone marrow depression = PANCYTOPENIA - Pulmonary fibrosis - Renal and hepatic disorders - TERATOGENIC folate deficiency
27
Azathioprine mechanism of action
PRODRUG —> 6-MCP with glutathione 2. —> thio-IMP 3. Converts GMP to GTP 4. Inhibit purine synthesis = less cell proliferation PURINE ANALOGUE
28
Azathioprine ADME
A: oral or IV D: doesn’t cross BBB, bound 30% M: xanthine oxidase —> 6-MCP (activation) E: urine
29
Avoid azathioprine with:
Allopurinol —> blocks xanthine oxidase Myelosuppressive ACE inhibitors
30
Azathioprine side effects BIG A
Bone marrow suppression = PANCYTOPENIA Increase risk of infections GI effects Alopecia
31
Mycophenolate mofetil mechanism of action
PRODRUG —> MPA 2. Inhibits iosine monophosphate dehydrogenase (IMPDH) 3. Inhibit guanine synthesis = less lymphocyte proliferation
32
Mycophenolate mofetil ADME
A: oral or IV D: extensively bound M: MPA—> inactive glucuronide E: urine
33
Azathioprine uses
- Acute glomerulonephritis - Autoimmune: SLE, RA - Crohn - Transplant
34
Mycophenolate mofetil side effects
WITH TACROLIMUS: diarrhea and alopecia - Bone marrow suppression = PANCYTOPENIA - Vomiting and diarrhea - Hypertension - Infections - PREGNANCY: anomalies, loss
35
Mycophenolate mofetil avoid with:
- Tacrolimus - Antiacids - Cholestyramine - Aciclovir
36
Immunosuppresors (10)
- Glucocorticoids - Cyclosporine - Tacrolimus - Sirolimus - Azathioprine - Methotrexate - Mycophenolate mofetil - Infliximab - Adalimumab - Rituximab
37
Glucocorticoids ____ (increase/decrease) T cell apoptosis
Increase
38
Short-acting glucocorticoids (2) Intermediate-acting (3) Long-acting (2)
Short: hydrocortisone, cortisone Intermediate: prednisone, prednisolone, methylprednisolone Long: dexamethasone, betamethasone
39
Which immunosuppresor should NOT be given to diabetics and why?
Tacrolimus Toxic to pancreatic b cells
40
Glucocorticoid ADME
A: oral, IM, IV D: rapidly removes from blood, distributed everywhere M: CYP3A4 E: urine
41
2 medications commonly used for synergistic immunosuppression
Sirolimus + glucocorticoids
42
Medication used in rheumatic diseases vs glucocorticoids
Mycophenolate mofetil
43
Methotrexate uses aside from immunosuppression
- Cancer, especially ALL - Ectopic pregnancy abortion
44
Infliximab acts against:
TNF-a
45
Anti TNF-a uses
Refractory therapy for chronic inflammatory sistemic Ex. RA, Crohn, psoriasis
46
Anti TNF-a side effects
- Reactivation of prior infections - Malignancy - Drug-induced lupus - Pancytopenia *heart failure patients
47
Infliximab ___ (can/can’t) be given with other immunosuppressors
CAN’T
48
Adalimumab target
TNF-a
49
Difference between infliximab and adalimumab
Infliximab is chimeric, given IV Adalimumab is humanized, given subcutaneously
50
Rituximab uses
- RA - ITP or TTP - MS - B-cell non-Hodgkin lymphoma
51
Rituximab main side effect
Risk of progressive multifocal leukoencephalopathy PML with latent JC virus
52
Immunomodulators (5)
- Glatiramer - Elapegdemasa - Perixaflor - Triciclib - Pagademasa
53
What is glatiramer acetate used for?
Treatment of relapsing MS
54
Glatiramer acetate mechanism of action
Acts as target for T cells instead of neuronal myelin Less Th1 (inflammatory), more Th2 (anti-inflammatory)
55
Glatiramer acetate ADME
A: subcutaneous D: doesn’t cross BBB
56
Perixaflor mechanism of action
Antagonism of CXCR4 —> block binding of SDF-1a = interfere with HSC retention in bone marrow = PERIPHERAL LEUKOCYTOSIS
57
Perixaflor uses
With FILGRASTIM - Non-Hodgkin’s lymphoma - Multiple myeloma
58
Perixaflor ADME
A: subcutaneous D: <58% bound M: n/a E: urine
59
Trilaciclib mechanism of action
CDK4 and CDK6 (kinase) inhibitor = decrease in bone marrow suppression caused by chemotherapy NOTE: teratogen
60
Elapegademase mechanism of action
Exogenous adenosine deaminase = reduction of toxic adenosine = increase lymphocytes
61
Elapegademase main use
SCID caused by ADA deficiency Note: IM administration
62
Pegademase bovine mechanism of action
Enzyme replacement for adenosine deaminase deficiency
63
Cyclosporine
Immunosuppressor
64
Tacrolimus
Immunosuppressor
65
Sirolimus
Immunosuppressor
66
Methotrexate
Immunosuppressor
67
Azathioprine
Immunosuppressor prodrug
68
Mycophenolate mofetil
Immunosuppressor prodrug
69
Infliximab
TNFa inhibitor
70
Adalimumab
TNFa inhibitor
71
Rituximab
CD20 antagonist
72
Glatiramer
Immunomodulator (MS)
73
Elapegdemase
Exogenous ADA enzyme (SCID)
74
Perixaflor
Immunostimulant (NHL and MM)
75
Trilaciclib
Reduce myelosuppression by chemotherapy Kinase inhibitor (SCLC)
76
Pegademase
ADA enzyme replacement (SCID)